home *** CD-ROM | disk | FTP | other *** search
- <text id=90TT2078>
- <title>
- Aug. 06, 1990: Battle Over The Abortion Pill
- </title>
- <history>
- TIME--The Weekly Newsmagazine--1990
- Aug. 06, 1990 Just Who Is David Souter?
- </history>
- <article>
- <source>Time Magazine</source>
- <hdr>
- MEDICINE, Page 79
- Battle over the Abortion Pill
- </hdr>
- <body>
- <p>Pressure is mounting to introduce the drug RU 486 in the U.S.
- </p>
- <p> If maintaining a woman's right to have an abortion tops the
- agenda of pro-choice forces, then introducing RU 486, the
- so-called abortion pill, into the U.S. ranks second. So far the
- foes of abortion have managed to keep the French-made drug out
- of the country. But last week a delegation of American
- feminists and scientists met in Paris with executives of
- Roussel Uclaf, the French company that manufactures the drug,
- and in Frankfurt with officials from Hoechst AG, Roussel's
- parent company. The Americans presented a petition signed by
- 115,000 people urging the distribution of RU 486 in the U.S.
- American support for the drug has also been growing rapidly
- among physicians. In June the American Medical Association
- passed a resolution supporting the "legal availability of RU
- 486 for appropriate research and, if indicated, clinical
- practice."
- </p>
- <p> Judged simply on efficacy and safety, RU 486 marks a major
- advancement over other pregnancy-ending techniques. The drug,
- which is most effective if used within seven weeks of
- conception, prevents the hormone progesterone from being
- absorbed by the lining of the uterus. Without that nourishment
- the uterus cannot support the growth of the embedded
- fertilized egg, and the woman miscarries. Taken with
- prostaglandin, a naturally occurring substance that causes mild
- uterine contractions, the drug is 95% effective. Developed in
- 1982 by Dr. Etienne-Emile Baulieu, RU 486 has so far been used
- by an estimated 55,000 women in 15 countries.
- </p>
- <p> France and China in 1988 formally approved use of the drug,
- and Roussel will shortly apply to market it in Britain. The
- company has refused to export it to any country unless several
- conditions are met, including the legality of abortion and its
- acceptance by public, political and medical opinion. According
- to Ariel Mouttet, head of international marketing for RU 486
- at Roussel, the sticking point in the U.S. is the political
- climate. Says she: "We don't want to enter into a social debate
- in the U.S."
- </p>
- <p> American advocates of RU 486 contend that the company is
- overestimating the opposition. A Louis Harris survey released
- last week found that 73% of American adults support abortion
- rights. Supporters believe that acceptance of RU 486 in other
- countries will lead women to push harder to bring it to the
- U.S. Doctors also warn that if the drug is not made officially
- available in the U.S., a black market for it will develop.
- </p>
- <p> Determined pro-choicers say RU 486 could enter the U.S.
- through the back door. The drug has potential as a therapy for
- endometriosis and breast cancer. If RU 486 were approved to
- treat these conditions, doctors could also prescribe it for
- abortions. Roussel opposes any deception. Says Dr. Baulieu: "RU
- 486 has to be sold as the abortion pill that it is."
- </p>
- <p>By Anastasia Toufexis. Reported by Andrew Purvis/ New York and
- Alexandra Tuttle/Paris.
- </p>
-
- </body>
- </article>
- </text>
-
-